Drawing for MENTIS NEUROTRACKER

USPTO serial 99823789

MENTIS NEUROTRACKER

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
HURTADO,DIANA V
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with MENTIS NEUROTRACKER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Laura Franco

Laura Franco Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.44 Montgomery Street, 36th FloorSan Francisco, CA 94104United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable mobile application for tracking patient health data; Downloadable mobile application for monitoring patient biometric data to predict seizures; Downloadable mobile application software for tracking and recording patient health data from home monitoring devices to predict seizures; Downloadable mobile application software for monitoring patient health data to predict seizures and sending automated notifications to first responders, caregivers, medical providers and family members; Downloadable computer application software for tracking patient health data; Downloadable computer application software for monitoring patient health data to predict seizures; Downloadable computer application software for tracking and recording patient health data from home monitoring devices to predict seizures; Downloadable computer application software for monitoring patient health data to predict seizures and sending automated notifications to first responders, caregivers, medical providers and family member; Downloadable computer application software for remote patient care management, namely, a mobile platform for monitoring patient information and biodata to predict seizures; Downloadable mobile application software for detecting seizures in real time from electroencephalography (EEG) data; Downloadable mobile application software for receiving and displaying real-time data from wearable electroencephalography (EEG) devices via wireless network; Downloadable computer application software used by healthcare professionals for clinical decision support, namely, software for displaying patient seizure history, medication adherence, trigger correlations, and AI-generated clinical summaries; Downloadable computer application software used by healthcare professionals for displaying individualized sudden unexpected death in epilepsy (SUDEP) risk scoresACTIVE—
042Providing temporary use of online, non- downloadable computer software for monitoring patient biometric data to predict seizures; Providing temporary use of online, non- downloadable computer software for monitoring patient health data to predict seizures and sending automated notifications to first responders, caregivers, medical providers and family members; Software as a service (SaaS) services featuring software for tracking patient health data and monitoring patient biometric data to predict seizures; Software as a service (SaaS) services featuring artificial intelligence (AI) software for predicting seizures; Software as a service (SaaS) services featuring software for integrating personal health data with provider electronic health records; Providing temporary use of online, non- downloadable computer software for tracking patient health data; Software as a service (SaaS) services featuring artificial intelligence (AI) software for detecting seizures from electroencephalography (EEG) data; Software as a service (SaaS) services featuring software for clinical decision support for healthcare professionals managing epilepsy patients; Software as a service (SaaS) services featuring software for collecting, de-identifying, and analyzing real-world patient health data for pharmaceutical research; Software as a service (SaaS) services featuring software for providing AI-verified seizure event data as clinical trial endpoints; Software as a service (SaaS) services featuring artificial intelligence (AI) software for predicting patient response to anti-seizure medications; Software as a service (SaaS) services featuring software for exchanging healthcare data with electronic health record systems using the Fast Healthcare Interoperability Resources (FHIR) standardACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 10, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 10, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 4, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 13, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 9, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 9, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 9, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 9, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 9, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 9, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 16, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 16, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 16, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 14, 2026DOCKASSIGNED TO EXAMINER—
Jul 31, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 14, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
May 14, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance